-20%

est. 2Y upside i

Healthcare

Medical Record Retrieval with Zero Human Error

Rank

#3902

Sector

Health IT / Revenue Cycle Management

Est. Liquidity

~4Y

Data Quality

Data: Low

Codes Health is an early-stage health IT startup (founded 2021) with no publicly verified ARR or funding data — classified as high-risk with a low-confidence rating.

Last updated: April 3, 2026

Bull (10%)+150%

Codes Health captures a meaningful wedge in the ~$10B AI medical coding SAM by integrating deeply with a mid-tier EHR (e.g., Athenahealth or eClinicalWorks), driving ARR past $50M+ by 2027 and positioning for a strategic acquisition by a Waystar, Availity, or private-equity RCM roll-up at a 10-12x ARR multiple — delivering a ~2.5x on current valuation assuming minimal additional dilution.

Base (50%)-10%

Codes Health grows at 30-40% YoY but remains subscale relative to well-capitalized incumbents like Epic and Waystar, reaching $20-30M ARR by 2027; multiple compression in health IT SaaS (peers trade at 6-9x ARR vs. earlier 15-20x peak) and additional dilutive funding rounds leave common equity holders roughly flat to modestly underwater relative to current grant price.

Bear (40%)-75%

Epic launches its native AI coding module (already in development as of 2025 for Epic-connected hospitals, covering ~35% of US patients), commoditizing standalone AI coders; Codes Health loses competitive deals and faces a down round or distressed acquisition below current valuation, with liquidation preferences from prior investors absorbing most proceeds and common stock near worthless.

Est. time to liquidity~4.0 years

Preference Stack Risk

moderate

Funding amount is not publicly disclosed; assuming $5-20M raised on an undisclosed valuation, the preference stack is likely moderate, but any down round or sub-valuation exit means common holders receive zero until preferences are cleared.

Dilution Risk

high

As a 2021-founded company with no disclosed profitability, Codes Health will almost certainly require additional funding rounds (Series B/C) before any liquidity event, likely diluting current common equity by 30-50%+.

Secondary Liquidity

none

No evidence of active secondary market or tender offer programs; employees should assume equity is fully illiquid until an acquisition or IPO.

Questions to Ask at the Interview

Strategic questions based on Codes Health's data — designed to show you've done your homework.

  • 1

    “Epic has announced AI-assisted coding features for its installed base — how is Codes Health's product differentiated enough that a hospital CFO would choose a standalone vendor over a native Epic module, and what's the retention data when a customer's EHR vendor launches a competing feature?”

  • 2

    “Given that the AI medical coding SAM is roughly $10B with ~15% penetration across all vendors today, what is Codes Health's current ARR and net revenue retention, and how does that benchmark against RCM SaaS peers like Waystar?”

  • 3

    “With the company founded in 2021 and still pre-scale, how is the board thinking about the liquidity timeline for employees — is the primary exit thesis a strategic acquisition or an eventual IPO, and have there been any secondary tender offer opportunities for early employees?”

Community

Valuation Sentiment

Our model estimates -20% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.